Inhibition of AMP deaminase as therapeutic target in cardiovascular pathology

Pharmacological Reports

Volumn 67, Issue 4, 2015, Pages 682-688

  Zabielska, Magdalena A ^a   Borkowski, Tomasz ^a   Slominska, Ewa M ^a   Smolenski, Ryszard T ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

AMP deaminase; AMP regulated protein kinase; Cardiac ischaemia; Endothelium; Nucleotide metabolism

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; ADENYLATE KINASE; AMP DEAMINASE INHIBITOR; CARDIOVASCULAR AGENT; HYDROLASE INHIBITOR; UNCLASSIFIED DRUG; ADENOSINE PHOSPHATE; ENZYME INHIBITOR;

CARDIOVASCULAR DISEASE; CELLS; DRUG TARGETING; ENDOTHELIUM; ENZYME INHIBITION; GENE FUNCTION; GENETIC DISORDER; GENETIC POLYMORPHISM; HEART; HEART MUSCLE CELL; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SKELETAL MUSCLE; TISSUES; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEM; ENZYMOLOGY; METABOLISM; PROCEDURES;

ADENOSINE MONOPHOSPHATE; AMP DEAMINASE; ANIMALS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; HUMANS;

EID: 84940459767     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.04.007     Document Type: Review

References (88)

1. R.L. Sabina, and D.K. Mahnke-Zizelman Towards an understanding of the functional significance of n-terminal domain divergence in human amp deaminase isoforms Pharmacol Ther 87 2000 279 283
2. C.M. Hohl Amp deaminase in piglet cardiac myocytes: effect on nucleotide metabolism during ischemia Am J Physiol 276 1999 H1502 H1510
3. N. Ogasawara, H. Goto, Y. Yamada, and T. Watanabe Distribution of amp deaminase isozymes in various human blood cells Int J Biochem 16 1984 269 273
4. N. Ogasawara, H. Goto, Y. Yamada, and T. Watanabe Distribution of amp-deaminase isozymes in rat tissues Eur J Biochem 87 1978 297 304
5. N. Ogasawara, H. Goto, Y. Yamada, T. Watanabe, and T. Asano Amp deaminase isozymes in human tissues Biochim Biophys Acta 714 1982 298 306
6. S. Yun, and C.H. Suelter Human erythrocyte 5′-amp aminohydrolase. Purification and characterization J Biol Chem 253 1978 404 408
7. W.N. Fishbein, R.L. Sabina, N. Ogasawara, and E.W. Holmes Immunologic evidence for three isoforms of amp deaminase (ampd) in mature skeletal muscle Biochim Biophys Acta 1163 1993 97 104
8. X. Wang, H. Morisaki, K. Sermsuvitayawong, I. Mineo, K. Toyama, N. Ogasawara, and et al. Cloning and expression of cdna encoding heart-type isoform of amp deaminase Gene 188 1997 285 290
9. D.K. Mahnke-Zizelman, J. D'Cunha, J.M. Wojnar, M.A. Brogley, and R.L. Sabina Regulation of rat amp deaminase 3 (isoform c) by development and skeletal muscle fibre type Biochem J 326 Pt 2 1997 521 529
10. Y. Moriwaki, T. Yamamoto, and K. Higashino Enzymes involved in purine metabolism - a review of histochemical localization and functional implications Histol Histopathol 14 1999 1321 1340
11. R.L. Sabina, N. Ogasawara, and E.W. Holmes Expression of three stage-specific transcripts of amp deaminase during myogenesis Mol Cell Biol 9 1989 2244 2246
12. J.M. Lowenstein Ammonia production in muscle and other tissues: the purine nucleotide cycle Physiol Rev 52 1972 382 414
13. T. Morisaki, M. Gross, H. Morisaki, D. Pongratz, N. Zollner, and E.W. Holmes Molecular basis of amp deaminase deficiency in skeletal muscle Proc Natl Acad Sci U S A 89 1992 6457 6461
14. R.L. Sabina, J.L. Swain, C.W. Olanow, W.G. Bradley, W.N. Fishbein, S. DiMauro, and et al. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle J Clin Invest 73 1984 720 730
15. T. Morisaki, R.L. Sabina, and E.W. Holmes Adenylate deaminase. A multigene family in humans and rats J Biol Chem 265 1990 11482 11486
16. R. Marquetant, N.M. Desai, R.L. Sabina, and E.W. Holmes Evidence for sequential expression of multiple amp deaminase isoforms during skeletal muscle development Proc Natl Acad Sci U S A 84 1987 2345 2349
17. J.M. Lowenstein The purine nucleotide cycle revisited [corrected] Int J Sports Med 11 Suppl. 2 1990 S37 S46
18. Y. Hellsten, E.A. Richter, B. Kiens, and J. Bangsbo Amp deamination and purine exchange in human skeletal muscle during and after intense exercise J Physiol 520 Pt 3 1999 909 920
19. D.K. Mahnke-Zizelman, R. Eddy, T.B. Shows, and R.L. Sabina Characterization of the human ampd3 gene reveals that 5′ exon usage is subject to transcriptional control by three tandem promoters and alternative splicing Biochim Biophys Acta 1306 1996 75 92
20. B. Norman, D.K. Mahnke-Zizelman, A. Vallis, and R.L. Sabina Genetic and other determinants of amp deaminase activity in healthy adult skeletal muscle J Appl Physiol (1985) 85 1998 1273 1278
21. J. Cheng, H. Morisaki, K. Toyama, N. Sugimoto, T. Shintani, A. Tandelilin, and et al. Ampd1: a novel therapeutic target for reversing insulin resistance BMC Endocr Disord 14 2014 96
22. J. Cheng, H. Morisaki, N. Sugimoto, A. Dohi, T. Shintani, E. Kimura, and et al. Effect of isolated amp deaminase deficiency on skeletal muscle function Mol Genet Metab Rep 1 2014 51 59
23. P.F. Binkley, A. Auseon, and G. Cooke A polymorphism of the gene encoding ampd1: clinical impact and proposed mechanisms in congestive heart failure Congest Heart Fail 10 2004 274 278 quiz 279-280
24. A.M. Feldman, D.R. Wagner, and D.M. McNamara Ampd1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression Circulation 99 1999 1397 1399
25. F. Carlucci, A. Tabucchi, B. Biagioli, F. Simeone, S. Scolletta, F. Rosi, and et al. Cardiac surgery: myocardial energy balance, antioxidant status and endothelial function after ischemia-reperfusion Biomed Pharmacother 56 2002 483 491
26. J.L. Swain, R.L. Sabina, J.J. Hines, J.C. Greenfield Jr., and E.W. Holmes Repetitive episodes of brief ischaemia (12 min) do not produce a cumulative depletion of high energy phosphate compounds Cardiovasc Res 18 1984 264 269
27. H. Van Belle, J. Wynants, and F. Goossens Formation and release of nucleosides in the ischemic myocardium. Is the guinea-pig the exception? Basic Res Cardiol 80 1985 653 660
28. C.M. Hohl, B. Hu, D.K. Wimsatt, R.H. Fertel, R.C. Starling, G.P. Brierley, and et al. Isolated myocytes from a normal human heart Prog Clin Biol Res 327 1990 735 742
29. C.M. Hohl, D.K. Wimsatt, G.P. Brierley, and R.A. Altschuld Imp production by atp-depleted adult rat heart cells. Effects of glycolysis and alpha 1-adrenergic stimulation Circ Res 65 1989 754 760
30. R.B. Jennings, and C. Steenbergen Jr. Nucleotide metabolism and cellular damage in myocardial ischemia Annu Rev Physiol 47 1985 727 749
31. J.K. Thakkar, D.R. Janero, C. Yarwood, and H.M. Sharif Modulation of mammalian cardiac amp deaminase by protein kinase c-mediated phosphorylation Biochem J 291 Pt 2 1993 523 527
32. Z. Kochan, R.T. Smolenski, M.H. Yacoub, and A.L. Seymour Nucleotide and adenosine metabolism in different cell types of human and rat heart J Mol Cell Cardiol 26 1994 1497 1503
33. J. Schrader, K. Kroll, M. Henrich, and H.M. Piper Coronary myocardial adenosine receptors Biomed Biochim Acta 46 1987 S421 S426
34. K. Kroll, J. Schrader, H.M. Piper, and M. Henrich Release of adenosine and cyclic amp from coronary endothelium in isolated guinea pig hearts: relation to coronary flow Circ Res 60 1987 659 665
35. A. Deussen, G. Moser, and J. Schrader Contribution of coronary endothelial cells to cardiac adenosine production Pflugers Arch 406 1986 608 614
36. J. Schrader, S. Nees, and E. Gerlach Radioimmunoassay for adenosine in biological samples Pflugers Arch 378 1978 167 171
37. S. Nees, V. Herzog, B.F. Becker, M. Bock, C. Des Rosiers, and E. Gerlach The coronary endothelium: a highly active metabolic barrier for adenosine Basic Res Cardiol 80 1985 515 529
38. S. Nees, E. Gerlach, C. Des Rosiers, M. Bock, B.F. Becker, and V. Herzog Recent knowledge about the metabolic regulation of coronary circulation, with a contribution on adenine nucleotide metabolism of coronary endothelial cells Z Kardiol 74 Suppl. 7 1985 87 91
39. C. Des Rosiers, S. Nees, and E. Gerlach Purine metabolism in cultured aortic and coronary endothelial cells Biochem Cell Biol 67 1989 8 15
40. H. Morisaki, T. Morisaki, L.K. Newby, and E.W. Holmes Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect J Clin Invest 91 1993 2275 2280
41. T. Morisaki, and E.W. Holmes Functionally distinct elements are required for expression of the ampd1 gene in myocytes Mol Cell Biol 13 1993 5854 5860
42. R.T. Smolenski, I. Rybakowska, J. Turyn, P. Romaszko, M. Zabielska, A. Taegtmeyer, and et al. Amp deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment Cardiovasc Drugs Ther 28 2014 183 189
43. M.H. Yacoub, A.H. Yuen, K.K. Kalsi, E.J. Birks, A. Taegtmeyer, P.J. Barton, and et al. C34t amp deaminase 1 gene mutation protects cardiac function in donors Transplantation 77 2004 1621 1623
44. A.B. Taegtmeyer, J.B. Breen, P. Rogers, P.H. Johnson, J. Smith, R.T. Smolenski, and et al. Effect of adenosine monophosphate deaminase-1 c34t allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation Am J Cardiol 103 2009 1457 1462
45. I. Rybakowska, S. Bakula, J. Klimek, R. Milczarek, R.T. Smolenski, and K. Kaletha Cardiac muscle amp-deaminase from a 10-year-old male heterozygous for the ampd1 c34t mutation Nucleosides Nucleotides Nucleic Acids 29 2010 453 456
46. K.K. Kalsi, A.H. Yuen, P.H. Johnson, E.J. Birks, M.H. Yacoub, and R.T. Smolenski Ampd1 c34t mutation selectively affects amp-deaminase activity in the human heart Nucleosides Nucleotides Nucleic Acids 24 2005 287 288
47. K.K. Kalsi, A.H. Yuen, I.M. Rybakowska, P.H. Johnson, E. Slominska, E.J. Birks, and et al. Decreased cardiac activity of amp deaminase in subjects with the ampd1 mutation - a potential mechanism of protection in heart failure Cardiovasc Res 59 2003 678 684
48. N.P. Riksen, B. Franke, W.J. Oyen, G.F. Borm, P. van den Broek, O.C. Boerman, and et al. Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34c>t variant of the ampd1 gene Eur Heart J 28 2007 1085 1091
49. B.D. Hand, S.M. Roth, M.H. Roltsch, J.J. Park, M.C. Kostek, R.E. Ferrell, and et al. Ampd1 gene polymorphism and the vasodilatory response to ischemia Life Sci 79 2006 1413 1418
50. D.R. Wagner, C. McTiernan, V.J. Sanders, and A.M. Feldman Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart Circulation 97 1998 521 524
51. E. Loh, T.R. Rebbeck, P.D. Mahoney, D. DeNofrio, J.L. Swain, and E.W. Holmes Common variant in ampd1 gene predicts improved clinical outcome in patients with heart failure Circulation 99 1999 1422 1425
52. K. Safranow, E. Czyzycka, A. Binczak-Kuleta, R. Rzeuski, J. Skowronek, A. Wojtarowicz, and et al. Association of c34t ampd1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure Scand J Clin Lab Invest 69 2009 102 112
53. K. Safranow, J. Suchy, K. Jakubowska, M. Olszewska, A. Binczak-Kuleta, G. Kurzawski, and et al. Ampd1 gene mutations are associated with obesity and diabetes in polish patients with cardiovascular diseases J Appl Genet 52 2011 67 76
54. R.L. Sabina, W.N. Fishbein, G. Pezeshkpour, P.R. Clarke, and E.W. Holmes Molecular analysis of the myoadenylate deaminase deficiencies Neurology 42 1992 170 179
55. D.K. Mahnke-Zizelman, F. van den Bergh, M.T. Bausch-Jurken, R. Eddy, S. Sait, T.B. Shows, and et al. Cloning, sequence and characterization of the human ampd2 gene: evidence for transcriptional regulation by two closely spaced promoters Biochim Biophys Acta 1308 1996 122 132
56. D.K. Mahnke-Zizelman, P.C. Tullson, and R.L. Sabina Novel aspects of tetramer assembly and n-terminal domain structure and function are revealed by recombinant expression of human amp deaminase isoforms J Biol Chem 273 1998 35118 35125
57. R.L. Sabina, T. Morisaki, P. Clarke, R. Eddy, T.B. Shows, C.C. Morton, and et al. Characterization of the human and rat myoadenylate deaminase genes J Biol Chem 265 1990 9423 9433
58. M.T. Bausch-Jurken, D.K. Mahnke-Zizelman, T. Morisaki, and R.L. Sabina Molecular cloning of amp deaminase isoform l. Sequence and bacterial expression of human ampd2 cdna J Biol Chem 267 1992 22407 22413
59. C. Bruno, C. Minetti, S. Shanske, G. Morreale, M. Bado, G. Cordone, and et al. Combined defects of muscle phosphofructokinase and amp deaminase in a child with myoglobinuria Neurology 50 1998 296 298
60. S. Tsujino, S. Shanske, J.E. Carroll, R.L. Sabina, and S. DiMauro Double trouble: combined myophosphorylase and amp deaminase deficiency in a child homozygous for nonsense mutations at both loci Neuromuscul Disord 5 1995 263 266
61. S.L. Heller, K.K. Kaiser, G.J. Planer, J.M. Hagberg, and M.H. Brooke Mcardle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency Neurology 37 1987 1039 1042
62. J.C. Rubio, M.A. Martin, J. Bautista, Y. Campos, D. Segura, and J. Arenas Association of genetically proven deficiencies of myophosphorylase and amp deaminase: a second case of 'double trouble' Neuromuscul Disord 7 1997 387 389
63. H. Nagao, S. Habara, T. Morimoto, N. Sano, M. Takahashi, K. Kida, and et al. Amp deaminase activity of skeletal muscle in neuromuscular disorders in childhood. Histochemical and biochemical studies Neuropediatrics 17 1986 193 198
64. J. Rico-Sanz, T. Rankinen, D.R. Joanisse, A.S. Leon, J.S. Skinner, J.H. Wilmore, and et al. Associations between cardiorespiratory responses to exercise and the c34t ampd1 gene polymorphism in the heritage family study Physiol Genomics 14 2003 161 166
65. D.G. Hardie Ampk: positive and negative regulation, and its role in whole-body energy homeostasis Curr Opin Cell Biol 33c 2014 1 7
66. V.G. Zaha, and L.H. Young Amp-activated protein kinase regulation and biological actions in the heart Circ Res 111 2012 800 814
67. F.Y. Li, K.S. Lam, H.F. Tse, C. Chen, Y. Wang, P.M. Vanhoutte, and et al. Endothelium-selective activation of amp-activated protein kinase prevents diabetes mellitus-induced impairment in vascular function and reendothelialization via induction of heme oxygenase-1 in mice Circulation 126 2012 1267 1277
68. L.H. Young, J. Li, S.J. Baron, and R.R. Russell Amp-activated protein kinase: a key stress signaling pathway in the heart Trends Cardiovasc Med 15 2005 110 118
69. C. Plaideau, Y.C. Lai, S. Kviklyte, N. Zanou, L. Lofgren, H. Andersen, and et al. Effects of pharmacological amp deaminase inhibition and ampd1 deletion on nucleotide levels and ampk activation in contracting skeletal muscle Chem Biol 21 2014 1497 1510
70. J.L. Anderson, J. Habashi, J.F. Carlquist, J.B. Muhlestein, B.D. Horne, T.L. Bair, and et al. A common variant of the ampd1 gene predicts improved cardiovascular survival in patients with coronary artery disease J Am Coll Cardiol 36 2000 1248 1252
71. N. Paolocci, B. Tavazzi, R. Biondi, Y.A. Gluzband, A.M. Amorini, C.G. Tocchetti, and et al. Metalloproteinase inhibitor counters high-energy phosphate depletion and amp deaminase activity enhancing ventricular diastolic compliance in subacute heart failure J Pharmacol Exp Ther 317 2006 506 513
72. A.C. Skladanowski, P. Stepnowski, K. Kleszczynski, and B. Dmochowska Amp deaminase in vitro inhibition by xenobiotics a potential molecular method for risk assessment of synthetic nitro- and polycyclic musks, imidazolium ionic liquids and n-glucopyranosyl ammonium salts Environ Toxicol Pharmacol 19 2005 291 296
73. S.R. Kasibhatla, B.C. Bookser, W. Xiao, and M.D. Erion Amp deaminase inhibitors. 5. Design, synthesis, and sar of a highly potent inhibitor series J Med Chem 44 2001 613 618
74. T. Borkowski, E.M. Slominska, C. Orlewska, A.H. Yuen, S. Al-Ayoubi, P. Siondalski, and et al. Biological efficiency of amp deaminase inhibitor: 3-[2-(3-carboxy-4-bromo-5,6,7,8-tetrahydronaphthyl)ethyl]-3,6,7,8-tetrahydroimida zo[4,5]-[1,3]diazepin-8-ol Nucleosides Nucleotides Nucleic Acids 29 2010 457 460
75. T. Borkowski, C. Orlewska, E.M. Slominska, A. Yuen, M. Lipinski, I. Rybakowska, and et al. Pharmacological inhibition of amp-deaminase in rat cardiac myocytes Nucleosides Nucleotides Nucleic Acids 27 2008 867 871
76. T. Borkowski, E.M. Slominska, C. Orlewska, S. Chlopicki, P. Siondalski, M.H. Yacoub, and et al. Protection of mouse heart against hypoxic damage by amp deaminase inhibition Nucleosides Nucleotides Nucleic Acids 29 2010 449 452
77. J. Ouyang, R.A. Parakhia, and R.S. Ochs Metformin activates amp kinase through inhibition of amp deaminase J Biol Chem 286 2011 1 11
78. J.T. Chin, J.J. Troke, N. Kimura, S. Itoh, X. Wang, O.P. Palmer, and et al. A novel cardioprotective agent in cardiac transplantation: metformin activation of amp-activated protein kinase decreases acute ischemia-reperfusion injury and chronic rejection Yale J Biol Med 84 2011 423 432
79. R.P. Agarwal, and R.E. Parks Potent inhibition of muscle 5'-amp deaminase by the nucleoside antibiotics coformycin and deoxycoformycin Biochem Pharmacol 26 1977 663 666
80. T. Admyre, L. Amrot-Fors, M. Andersson, M. Bauer, M. Bjursell, T. Drmota, and et al. Inhibition of amp deaminase activity does not improve glucose control in rodent models of insulin resistance or diabetes Chem Biol 21 2014 1486 1496
81. H. Funaya, M. Kitakaze, K. Node, T. Minamino, K. Komamura, and M. Hori Plasma adenosine levels increase in patients with chronic heart failure Circulation 95 1997 1363 1365
82. M. Kitakaze, M. Hori, and T. Kamada Role of adenosine and its interaction with alpha adrenoceptor activity in ischaemic and reperfusion injury of the myocardium Cardiovasc Res 27 1993 18 27
83. B.C. Gho, R.G. Schoemaker, M.A. van den Doel, D.J. Duncker, and P.D. Verdouw Myocardial protection by brief ischemia in noncardiac tissue Circulation 94 1996 2193 2200
84. C.M. Aherne, E.M. Kewley, and H.K. Eltzschig The resurgence of a2b adenosine receptor signaling Biochim Biophys Acta 1808 2011 1329 1339
85. G. Hasko, and Cronstein B.N. Adenosine An endogenous regulator of innate immunity Trends Immunol 25 2004 33 39
86. H.K. Eltzschig, M. Faigle, S. Knapp, J. Karhausen, J. Ibla, P. Rosenberger, and et al. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and cd26 Blood 108 2006 1602 1610
87. M. Cieslak, F. Kukulski, and M. Komoszynski Emerging role of extracellular nucleotides and adenosine in multiple sclerosis Purinergic Signal 7 2011 393 402
88. O. Katayama, S.J. Ledingham, M. Amrani, R.T. Smolenski, D.R. Lachno, J. Jayakumar, and et al. Functional and metabolic effects of adenosine in cardioplegia: role of temperature and concentration Ann Thorac Surg 63 1997 449 454 discussion 454-445